首页> 外国专利> PHARMACEUTICAL COMPOSITION COMPRISING A VANADIUM COMPOUND AND AT LEAST A COMPONENT SELECTED FROM A NA+/H+ EXCHANGER, CYCLO-OXYGENASE INHIBITORS AND CASPASE INHIBITORS

PHARMACEUTICAL COMPOSITION COMPRISING A VANADIUM COMPOUND AND AT LEAST A COMPONENT SELECTED FROM A NA+/H+ EXCHANGER, CYCLO-OXYGENASE INHIBITORS AND CASPASE INHIBITORS

机译:包含钒化合物并至少选自NA + / H +交换剂,环氧化酶抑制剂和Caspase抑制剂的药物组合物

摘要

Pharmaceutical composition for the prophylactic treatment of secondary injury of tissue, said secondary injury being induced by primary injury of mainly surrounding tissue and being the result of a traumatic event, wherein the pharmaceutical composition comprises a physiologically acceptable vanadium compound and at least a component selected from Na+/H+ exchanger inhibitors, cyclo-oxygenase inhibitors and caspase inhibitors, as active components. The pharmaceutical composition is preferably administered in a single dose and preferably before or immediately or shortly after the traumatic event.
机译:用于预防性治疗组织继发性损伤的药物组合物,所述继发性损伤由主要周围组织的原发性损伤诱发并且是创伤事件的结果,其中所述药物组合物包含生理学上可接受的钒化合物和至少一种选自以下的组分Na + / H +交换抑制剂,环加氧酶抑制剂和半胱天冬酶抑制剂作为活性成分。药物组合物优选以单剂量给药,并且优选在创伤事件之前或之后或之后立即给药。

著录项

  • 公开/公告号WO0145717A3

    专利类型

  • 公开/公告日2002-02-21

    原文格式PDF

  • 申请/专利权人 GHOST HOLDING B.V.;GHO CONRADUS GHOSAL;

    申请/专利号WO2000NL00932

  • 发明设计人 GHO CONRADUS GHOSAL;

    申请日2000-12-20

  • 分类号A61K33/24;A61K31/54;A61P9/10;

  • 国家 WO

  • 入库时间 2022-08-22 00:38:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号